Epilepsy Impact Scale
The investigators are developing a questionnaire that can quickly measure the impact that epilepsy has on a person's life. This questionnaire will be useful in following whether the impact of epilepsy increases, decreases or stays the same over time. The results also may point out areas that would benefit from discussion or attention in visits with your doctor.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Questionnaire Development for a Comprehensive Scale to Measure the Impact of Epilepsy on Life.|
- Validation of a concise question set [ Time Frame: Up to 1 year for question set validation, data presentation within up to 1.5 years ] [ Designated as safety issue: No ]
- Correlation of subscales [ Time Frame: Up to 1.5 years ] [ Designated as safety issue: No ]Correlation of subscales of the study questionnaire with previously validated scales, including QoLiE-39, NHS Seizure Severity Scale, Liverpool side effects scale, Beck Depression Index
|Study Start Date:||July 2012|
|Estimated Study Completion Date:||December 2015|
|Estimated Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|
People with epilepsy
People with epilepsy who have have had at least one seizure in the prior year.
|Other: Interviews and questionnaires|
The investigators have used a set of broad open-ended questions about the impact of epilepsy on a person's life to formulate a long list of questions to characterize the impact the seizures, medications, and comorbidities that you are having. In the future, this will be boiled down to a short list of questions.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01833234
|United States, California|
|Stanford University School of Medicine|
|Stanford, California, United States, 94305-5235|
|Principal Investigator:||Robert S Fisher, MD, PhD||Stanford University|